In 48 out of the 72 cancer entities analyzed, moderate or strong expression of SHIP1 was detected, and 26 out of the 48 positive entities showed staining of SHIP1 in at least 10% of the samples analyzed. This evidence concerns the gene INPP5D and cancer.